Rzepień pospolity ( Xanthium strumarium L.) – surowiec zielarski o wielokierunkowym działaniu farmakologicznym. Analiza fitochemiczna związków fenolowych

1. Bown D.: Wielka encyklopedia ziół. Muza, Warszawa, 1999, 222, 365, 372. 2. Pitcher D.: Element Stewardship Abstract for Xanthium strumarium. http://www.tncweeds. ucdavis. edu/esadocs/documnts/xatstr.html. 3. USDA, ARS, National Genetic Resources Program. Germplasm Resources Information Network (GRIN). http://www.ars-grin.gov/cgi-bin/npgs/html/taxlist.pl?Xanthium. 4. Wolski T., Zwolan W.: Rzepień pospolity – chwast o właściwościach leczniczych. Wiad. Ziel. 2002, 11, 20. 5. Broda B., Mowszowicz J.: Przewodnik do oznaczania roślin leczniczych, trujących i użytkowych. PZWL, Warszawa 2000, 708. 6. Dharmananda S.: Safety issues affecting Chinese herbs: the case of Xanthium. http://www.itmonline.org/arts/xanthium.htm. 7. Flora of Taiwan, National Taiwan University. http://www.pick4.pick.uga.edu/mp/20?search =Xanthium+strumarium. 8. Hegi G.: Illustriette Flora von Mittel Europa. Universität München 1954, 498. 9. Lee J.M.: Common Coclebur. Xanthium strumarium.Iowa State University, Agronomy Demartement. http://www.agron.iastate.edu/~weeds/WeedBiolLibrary/u4coclke1.html. 10. Misfud S.: Malta Wild Plants. http://www.maltawildplants.com/ASTR/Xanthium_strumarium.html. 11. Plants For A Future. http://www.scs.leeds.ac.uk/cgi-bin/pfaf/arr_html?Xanthium+ strumarium &CAN=LATIND. 12. Lloyd S.: Bathurst burr. Farmnote. Demartement of Agiculture – Western Australia. http://www.agric.wa.gov.au/agency/Pubns/farmnote/200/f04100.html. 13. Uchytli R.J.: Xanthium strumarium. U.S. Department of Agriculture Forest Service, Rocky Mountain Research Station, Fire Sciences Laboratory. http://www.fs.fed.us/databese/feis/. 14. Varner B.L. i wsp.: Detection of Cockleburs ( Xanthium strumarium L.) in Syberians Using Hyperspectral Imaginery. http://www.nal.usda.gov/ttic/tektran/data/000011/40/00001140 10.html. 15. Bernasconi P., Woodworth A.R.: Gene exhibiting resistance to acetolactate synthase inhibitor herbicides. Unated States Patent, numer: 5, 633, 437. 16. Fiałkowski D.: Flora roślin naczyniowych Lubelszczyzny. Tom 1, LTN. Lublin 227, 1994. 17. Fiałkowski D.: Flora roślin naczyniowych Lubelszczyzny. Tom 1, LTN. Lublin 612, 1995. 18. Mowszowicz J.: Przewodnik do oznaczania krajowych roślin zielarskich. PWRiL, Warszwa 1983, 397. 19. Mowszowicz J.: Krajowe chwasty polne i ogrodowe. Przewodnik do oznaczania. PWRiL, Warszwa 1986, 559. 20. Sarwa A.J.: Wielki leksykon roślin leczniczych. Książka i Wiedza, Warszawa 2001, 386. 21. Świejkowski L., Rośliny lecznicze i przemysłowe – klucz do oznaczania. Libra, Warszawa 1990, 439. 22. Hsu F.L. i wsp.: Cafeic acid as a active principle from the fruit of Xanthium strumarium to lower plasma glucose in diabetic rats. Planta Med. 2000, 66, 288. 23. Kim I.T. i wsp.: Methanol Extract of Xanthium strumarium L. Possesses Anti-inflamatory and Anti-nociceptive Activities. Biol. Pharm. Bull. 2005, 28, 94. 24. Kim Y.S. i wsp.: Two cytotoxic sesquiterpene lactones from the leaves of Xanthium strumarium and their in vitro inhibitory activity on farnesyltransferase. Planta Med. 2003, 69, 375. 25. Mehta P. i wsp.: Antimicrobial properties of some plant extracts against bacteria. Folia Microbiol. 1983, 6, 467. 26. Murillo-Alvarez J.I. i wsp.: Antimicrobial and cytotoxic activity of some medicinal plants from Baja California Sur (Mexico). Pharm. Biol. 2001, 6, 445. 27. Nairman F. i wsp.: Anti- Helicobacter pylori activities of six Iranian plants. J. Etnopharmacol. 2004, 9, 146. 28. Talkal T.S. i wsp.: In vitro and in vivo antitrypanosomal activity of Xanthium strumarium leaves. J. Ethnopharmacol. 1995, 49, 141. 29. Talkal T.S. i wsp.: In vitro and in vivo antitrypanosomal activity of Xanthium strumarium leaves and Parthenium hysterophorus flowers. Indian-Drugs 1995, 32, 433. 30. Herbari Virtual de les Illes Balears. Labolatori de Botŕnica, Department de Biologia, Universitat de les Illes Balears. http://www.herbarivirtual.uib.es/imatges/81912.jpg. 31. Maeterlinck M.: Inteligencja kwiatów. R.Wagner, Warszawa 1948. 32. Dasgupta J., Kundu B.C.: Pharmacognositc studies of Xanthium strumarium Linn. I. Root. Planta Med. 1963, 11, 470. 33. Dharmananda S.: Appendix: Xanthium in traditional and modern Chinese medical practice. http://www.itmonline.org./arts/xanthium.html. 34. Felther H.W.: The Eclectic Materia Medica, Pharmacognosy & Terapeutics. http://www.vu.edu.au/library/pdf/5SciencePostgraduateSubjects.pdf. 35. Khafagy S.M. i wsp.: Phytochemical investigation of Xanthium strumarium.Planta Med. 1974, 26, 75. 36. Zwolan W. i wsp.: Chromatographic analysis of phenolic acids present in vegetative and generative parts of Xanthium strumarium L. Herba Pol. 3/4, 23. 37. Ma Y.T. i wsp.: Thiazinedione from Xanthium strumarium L. Phytochem. 1998, 48, 1083. 38. Sheu S.J. i wsp.: Determination of Xanthium constituents by high performance liquid chromatography and capillary electrophoresis. J. Food & Drugs Anal. 2003, 11, 67. 39. Madej J.: Analiza fitochemiczna części nadziemnych i podziemnych rzepienia pospolitego Xanthium strumarium L. Praca magisterska, AM, Lublin 2004. 40. Ziętek E.; 2005. Analiza steroli i triterpenów w częściach podziemnych i nadziemnych Xanthium strumarium L. Praca magisterska, AM, Lublin. 41. Dharmananda S.: Safety issues affecting Chinese herbs: Pyrrolizidine alkaloids. http://www.itmonline.org/arts/pas.htm. 42. Lipiec M.: Analiza fitochemiczna ziela i owoców rzepienia pospolitego Xanthium strumarium L. Praca magisterska, AM, Lublin 2002. 43. Ahija M.M., Nigam S.S.: Chemical investigation of the essential oil from the leaves of Xanthium strumarium (Linn.). Flavour Ind. 1970, 1, 627. 44. Habibi Z. i wsp.: Composition of the essetial oil of Xanthium brasilicum Vello from Iran. J. Esential Oil Res. 2004, 1, 25. 45. Khafagy S.M., Metwally A.M.: Isolation of a crystalline sesquiterpenic keto-lactone from Xanthium occidentale.Planta Med. 1970, 18, 318. 46. Saxena V.K., Mandal S.K.: A xanthanolide from Xanthium strumarium. Phytochemistry, 1994, 4, 1080. 47. Roth L. i wsp.: Giftpflanzen Pflanzengifte. Nikol, Hamburg 1994, 738. 48. Ahmed A.A. i wsp.: A xanthanolide diol and a dimeric xanthanolide from Xanthium species. Planta Med. 1999, 65, 470. 49. Mahmoud A.A.: Xanthanolides and xanthane epoxide derivatives from Xanthium strumarium. Planta Med. 1998, 64, 724. 50. Malik M.S. i wsp.: Xanthanolides from Xanthium strumarium. Phytochem. 1993, 32, 206. 51. Marco J.A. i wsp.: Xanthanolides from Xanthium:absolute configuration of xanthanol, isoxanthanol and their C-4 epimers. Phytochem. 1993, 34, 1569. 52. Cole R.J. i wsp.: Isolation and redefinition of the toxic agent from cocklebur ( Xanthium strumarium). J. Agricult. Food Chem. 1980, 28, 1330. 53. Hatch R.C. i wsp.: Toxicologic study of carboxyatractyloside (active principle in coclebur – Xanthium strumarium) in rats treated with enzyme indecers and inhibitors and glutathione precursor and depletor. Am. J. Vet. Res. 1982, 43, 111. 54. Luciani S., Varotto R.: Difference between atractyloside and carboxyatractyloside on the binding to the mitochondrial membrane. Febs Letteres, 1975, 56, 194. 55. MacLeod J.K. i wsp.: Two cytotoxic kaurene glycosides from the burrs of Xanthium purgens.J. Nat. Prod. 1990, 53, 451. 56. Dharmananda S.: Gallnuts and the Uses of Tannins in Chinese Medicine. http://www.itmonline.org/arts/gallnuts.htm. 57. Aggarwal B.B. i wsp.: Nuclear Factor – κB: A Holly Grail in Cancer Prevention and Therapt. Current Signal Transduction Therapy 2006, 1, 25. 58. Lavault M. i wsp.: Antileishmanial and antifungal activities of xanthanolides isolated from Xanthium marcoaprum. Fitoterapia 2005, 76, 363. 59. Moon E.Y. i wsp.: Immunomodulating activities of water extract from Xanthium strumarium (II): Immunomodulating effects of the water layer after treated with chloroform. Arch. Pharm. Res. 1991, 14, 217. 60. Roussakis Ch. i wsp.: Cytotoxic activity of xanthatin and the crude extracts of Xanthium strumarium.Planta Med. 1994, 60, 473. 61. Sato Y. i wsp.: A xanthanolide with potent antibacterial activity against methicilin-resistant Staphylococcus aureus. Pharm. Pharmacol. 1997, 49, 1042. 62. Tripathi R.N. i wsp.: Fungitoxicity of pollen grains with special reference to Xanthium strumarium ( Compositae). Grana 1985, 24, 61. 63. Cai Y. i wsp.: Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sciences 2004,74, 2157. 64. Hong Ch.H. i wsp.: Evaluation of natural products on inhibition of inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) in cultured mouse macrophage cells. J. Ethnopharmacol. 2002, 83, 153. 65. Kang G.D. i wsp.: Screening and comparison of antioxidant activity of solvent extracts of herbal medicines used in Korea. J. Ethnopharmacol. 2003, 87, 231. 66. Lae H.J. i wsp.: Inhibition of nitric oxide synthesis by 8-epi-xanthatin in PLS-activated macrophages. Yakhak Hoechi 1998, 42, 540. 67. Prieto J.M. i wsp.: Identification of a 5-LOX inhibitor from Xanthium spinosum L. Rev. Fitoterapia. Anual Congres Barcelona. 2002, A056. 68. Shale T.L. i wsp.: Screening of medicinal plants used in Lesotho for anti-bacterial and anti-inflammatory activity. J. Ethnopharmacol. 1999, 67, 347. 69. Coelho de Souza G. i wsp.: Ethnopharmacological studies of antimicrobial remedies in the south of Brazil. J. Ethnopharmacol. 2004, 90, 135. 70. Pinel B. i wsp.: Synthesis of reduced xanthatin derivatives and in vitro evaluation of their antifungal activity. J. Enzyme. Inhibit. Med. Chem. 2005, 20, 575. 71. Li Y. i wsp.: In vitro anti- Helicobacter pylori action of 30 Chinese herbal medicines uses to treat ulcer diseases. J. Ethnopharmacol. 2005, 98, 329. 72. Wang Y.Ch. i wsp.: Screening of anti- Helicobacter pylori herbs deriving form Taiwanese folk medicinal plants. FEMS Immunology and Med. Microbiol. 2005, 43, 295. 73. Abdel-Malek S. i wsp.: Drug leads from the Kallawaya herbalists of Bolivia. 1. Background, rationale, protocol and anti-HIV activity. J. Ethnopharmacol. 1996, 50, 157. 74. Rocha L.G. i wsp.: A review of natural products with antileishmanial activity. Phytomed. 2005, 12, 514. 75. Kawazu K. i wsp.: Xanthium and 8-epi-xanthatin as insect development inhibitors from Xanthium candense Mill. Experientia 1979, 35, 1294. 76. Nieves L.J. i wsp.: Effecto diuretico del Xanthium strumarium L. (guizazo de caballo). Rev. Cubana Planta Med. 1999, 1, 22. 77. Kupiecki F.P. i wsp.: Isolation and characterization of a hypoglycemic compound from Xanthium strumarium. J. Pharm. Sci. 1974, 63, 1166. 78. Li W.L. i wsp: Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol. 2004, 92, 1-21. 79. Turner C.E., Craig J.C.: Hypoglycemic compound and method of preparing. Unated States Patent, number: US 3922263. 80. Sucher N.J.: Insights from molecular investigations of traditional Chinese herbal stroke medicines: Implications for neuroprotective epilepsy therapy. Epilepsy & Behavior, 2006, 8, 350. 81. Balachandran P., Govindarajan R.: Cancer–an ayurvedic perspective. Pharm. Res. 2005, 51, 19. 82. Graham J.G. i wsp.: Plants used against cancer – an extension of the work of Jonathan Hartwell. J. Ethnopharmacol. 2000, 73, 347. 83. Ancuceanu R.V.: Pharmacologically Active Natural Compounds for Lung Cancer. Alter. Med. Rev. 2004, 9, 402. 84. Menon G.S. i wsp.: Interaction of microtubules with activ principles of Xanthium strumarium. Phys. Chem. Phys. Med. NMR 2001, 33, 153. 85. Steward M.J., Steenkamp V.: The biochemistry and toxicity of atractyloside. A review. Ther. Drug Monit. 2000, 22, 641. 86. Kephalas T. i wsp.: Production of carboxyatractyloside and atractyloside by cell suspension cultures of Atractylis gummifera. Phytochem. 1999, 51, 53. 87. Gailard Y., Pepin G.: Poisoning by plant material: rewiev of human cases and analytical determination of main toxins by high-performance liquid chromatography – (tandem) mass spectrometry. J. Chromatogr. B 1999, 733, 181. 88. Stuart B.P. i wsp.: Cocklebur ( Xanthium strumarium L. var. strumarium) intoxication in swine: review and redefinition of the toxic principle. Vet. Pathol. 1981, 18, 386. 89. Turgut M. i wsp.: Carboxyatractyloside poisoning in humans. Ann. Ter. Ped. 2005, 25, 125. 90. Ailmets Senses – Treasure of East. http://www.treasureofeast.com/fromulas.html. 91. Balance Healthcare. Products, Services and Support for Profesionals. http://www.balanceheatlhcare.com/subCat.aps?subCat_id=1. 92. China–West #06 Children Xanthium Formula. http://www.nutriwest.com/cat/cw-0006.html. 93. Commitee on Chinese Medicine and Pharmacy, Department of Health, Taiwan. http://www.ccmp.gov.tw/en/information/formula.asp?relno=52&selno=0&no=&PageNo=10. 94. Jade Screen & Xanthium Formula. http://www.spanda.com/herbs/golden/jsx.html. 95. Mengjun Y.: Nano Medicine ´Huodan Biyan´ nad its preparing process. United States Patent Number: CN 1368349. 96. Zhang Y., Zhang J.: Preparation method of Xanthium sibiricum volatile oil pharmaceutical. United States Patent Number: CN 1053364. 97. Farmakopea Polska IV. PZWL, Warszawa 1970. 98. Farmakopea Polska VI. PTFarm. Warszawa 2002. 99. Ibrahim R.K., Towers G.H.N.: The identification by chromatography, of plant phenolic acids. Arch. Biochem. Biophys. 1960, 87, 125. 100. Jerzmanowska Z.: Substancje roślinne, metody wyodrębniania. T.1. PWN, Warszawa 1970. 101. Lewandowska A: Analiza związków fenolowych występujących w rzepieniu pospolitym ( Xanthium strumarium L.) ze szczególnym uwzględnieniem flawonoidów i garbników. Praca magisterska, AM. Lublin 2006.